A5003863214- Esophageal and GI Pathology
- Gastroesophageal reflux and treatments
- Gastrointestinal Bleeding Diagnosis and Treatment
- Inflammatory Bowel Disease
- Eosinophilic Esophagitis
- Gastric Cancer Management and Outcomes
- Microscopic Colitis
- Gastrointestinal disorders and treatments
- Esophageal Cancer Research and Treatment
- Liver Disease Diagnosis and Treatment
- Gastrointestinal Tumor Research and Treatment
- Hepatocellular Carcinoma Treatment and Prognosis
- Innovations in Medical Education
- Nutrition and Health in Aging
- PI3K/AKT/mTOR signaling in cancer
- Liver Diseases and Immunity
- Clinical Nutrition and Gastroenterology
- Liver Disease and Transplantation
- Hemostasis and retained surgical items
- Tracheal and airway disorders
- Dysphagia Assessment and Management
- Lung Cancer Treatments and Mutations
- Blood transfusion and management
- Pediatric Hepatobiliary Diseases and Treatments
- Social Media in Health Education
University of California, Irvine
2018-2021
University of California, Irvine Medical Center
2018-2020
Toronto General Hospital
2014-2018
University of Toronto
2014-2018
Mount Sinai Hospital
2017
McGill University
2014
Sinai Hospital
2013
Children's Hospital of Eastern Ontario
2010-2012
University of Ottawa
2010-2012
Background and study aims This preliminary was conducted to determine the feasibility safety of endoscopic augmentation gastroesophageal junction (GEJ) using Apollo OverStitch suturing system in patients with reflux disease (GERD) symptoms. Patients methods Endoscopic GEJ performed on 10 consecutive data were analyzed retrospectively. Using a double-channel gastroscope affixed platform, interrupted sutures placed gastric side 2 layers order create narrowed elongated GEJ. Results Technical...
Background and study aims A novel technique for Barrett's esophagus (BE) ablation, termed hybrid APC, has recently been developed. The of this US pilot were to evaluate the efficacy, tolerance safety APC treatment BE. Patients methods with biopsy-proven BE referred our tertiary care center over a 12-month period mucosal ablation eligible study. Efficacy was measured on follow-up endoscopy by demonstrating either reduction visible or biopsies proving complete resolution intestinal metaplasia...
Current clinical practice guidelines suggest that patients with ulcerative colitis (UC) hospitalized because of a disease flare should be offered normal diet, unless such diet is not tolerated. Studies have demonstrated iatrogenic malnutrition from unjustified or inappropriate nil per os (NPO) clear liquid (CLD) orders. In this study, we aim to characterize the burden problem in UC.We conducted retrospective cohort study all UC admitted gastroenterology service general internal medicine at...
Previous case reports have described esophagitis thought to be secondary crizotinib, an oral tyrosine-kinase inhibitor used in the treatment of anaplastic lymphoma kinase- (ALK-) positive non-small cell lung cancer (NSCLC). In those reports, interval development was between two days and three months after initiating or reinitiating crizotinib therapy. We present a woman who developed ulcerative ten beginning therapy, which is highly unusual. believe provoking factor change her medication...
Abstract Background There is growing interest in developing impedance planimetry as a tool to enhance the clinical outcomes for endoscopic and surgical management of achalasia. The primary aim this study was determine whether measurements can predict response reflux following peroral myotomy (POEM). Methods A multicenter cohort patients with achalasia undergoing POEM established from prospective databases retrospective chart reviews. Patients who underwent before after were included....
Hepatocellular carcinoma most commonly occurs in patients with underlying liver disease or cirrhosis. We describe a case of hepatocellular 34-year-old man Crohn’s treated azathioprine and infliximab. The patient had no history complete autoimmune viral workup was unremarkable. Unfortunately, the developed widespread metastatic passed away 5 months after his initial diagnosis. mechanism patients’ is poorly understood may include both autoimmunity treatment-related complications. Previous...
Hepatocellular carcinoma rarely occurs in patients without underlying cirrhosis or liver disease. While inflammatory bowel disease has been linked to certain forms of disease, hepatocellular is exceedingly rare these patients. We report the twelfth case a patient with Crohn's The 61-year-old longstanding who was treated azathioprine and found have elevated enzymes new 3-cm mass on ultrasound. A complete workup for unremarkable biopsy revealed carcinoma. underwent hepatic resection, there no...
Introduction . There is limited data evaluating physician transfusion practices in patients with acute upper gastrointestinal bleeding (UGIB). Methods A web-based survey was sent to 500 gastroenterologists and hepatologists across Canada. The included clinical vignettes where physicians were asked choose thresholds. Results response rate 41% (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mi>N</mml:mi><mml:mo>=</mml:mo><mml:mn...
Hepatitis B reactivation can occur with various forms of immunosuppression. Cyclophosphamide, Bortezomib, and Dexamethasone (CYBOR-D) chemotherapy is commonly used for the treatment multiple myeloma has not been noted in guidelines to be causative HBV reactivation. Indeed, current do recommend providing antiviral prophylaxis patients prior infection. We present a case as result CYBOR-D autologous stem cell transplant which complicated by patient’s partner who developed acute hepatitis B. Our...
Acute ischemic proctitis is a rare condition usually resulting from severe vascular disease or an acute occlusion. The diagnosis made on endoscopy, and mortality rates approach 20–40%. Many patients will require proctectomy as the definitive treatment, especially for gangrenous proctitis. We describe unusual presentation of in patient without preexisting other precipitants. Furthermore, our recovered entirely with conservative management intravenous antibiotics alone. review existing...
Introduction: A novel technique for Barrett’s esophagus (BE) ablation, termed hybrid argon plasma coagulation (APC), has recently been developed. This raises mucosa using a high-pressure water jet to achieve needleless submucosal injection. Hybrid ablation may reduce injury the underlying submucosa, potentially decreasing rates of stricture formation and pain. Current literature on this method is limited. The aims pilot study were evaluate efficacy, tolerance safety Hybrid-APC treatment BE....